Consistently, our data revealed significantly elevated fecal IgA levels in LE patients at baseline, which decreased following treatment in both the RTX and conventional therapy groups—although the decline was more pronounced in the RTX group, the difference did not reach statistical significance.
← all excerpts
Low-dose rituximab in lupus enteritis: a comparative study on its efficacy in modulating mucosal immunity and reducing inflammation.
1
—
—